“There is nothing more difficult to carry out, nor more doubtful of success, nor more dangerous to handle, than to initiate a new order of things. For the reformer has enemies in all those who profit by the old order, and only lukewarm defenders in all those who would profit by the new order.”

Niccolò Machiavelli: “The Prince”

David Cooper Associates is an independent business development practice. For over 30 years we have helped our clients achieve commercial advantage from technology based new business development programmes.

We advise clients in identifying opportunities to add value, we optimise the allocation of resources, and we drive the implementation process. We create a complete package tailored to each client’s specific objectives.

Developing business strategies is a high risk activity and the complexities are frequently underestimated. Today’s volatile economic climate and the international nature of technology based markets demand flexibility. DCA’s depth of experience provides flexible strategies based upon well researched advice and creative problem solving.

For further information about DCA and our activities please use the menu above. alternatively, you can always contact us if you have a specific query.

read more


“Almost always, requests for resources require making two decisions: Should we support this business idea? and Is this proposal the right way to go about it? Most capital budgeting processes are set up to vet projects (in other words, they’re aimed at the second question, not the first). It is usually possible to carry out fairly rigorous quantitative analysis comparing the plan of action in a proposal with alternatives. It is important that this analysis be done-and it is often done ad nauseam. But our research shows that the first question, the business question, is more important and far more difficult to answer-and it is often ignored.”

Joseph L. Bowerr & Clark G. Gilbert: “From Resource Allocation to Strategy From Resource Allocation to Strategy”

Examples of our assignments include:

Acquisition Programme
DCA advised the management of a Swiss multinational corporation on the creation of a healthcare and life science strategic business unit. We subsequently identified suitable acquisition targets consistent with the company’s strategy and successfully executed the first acquisition.

DCA advised a holding group with US and UK biotechnology manufacturing facilities. We controlled the divestiture of a subsidiary whose early stage products were found to be no longer consistent with the strategic direction of the quoted parent.

Drug development tools
DCA advises central research groups of pharmaceutical companies on the acquisition of strategically important enabling technologies for their early stage drug discovery programmes.

Due Diligence
DCA advises on technology and marketing due diligence

European Biologicals Company
DCA assists the management with external collaborations and business development.

European Business Development
DCA advised the Chairman of a US healthcare group based in New York on the development of a marketing and distribution strategy for replicating the company’s domestic success in European export markets.

Licensing biotechnology
DCA advised the management of a Boston based, US biotechnology company. We advised in the early stage funding and formation of the company, assisted in the development of a number of the company’s diagnostic and therapeutic intellectual properties and arranged licensing and distribution agreements.

Intellectual Property Assignment
DCA conducted an investigation on behalf of a government agency to identify commercially attractive university research. We advised the managing board on identifying, protecting and commercially exploiting the inherent value of the intellectual property.

Interim management Assignment
Most recently assisting an overseas management group establish a European subsidiary.

Marketing and Distribution
DCA advises the management of companies in North America, Europe, Japan, and around the Pacific Rim on the exploitation of their intellectual property and the marketing and distribution of their products in export markets.

DCA advised the Directorate of a UK government-owned laboratory on the sale of one of its manufacturing facilities.

Professional practices
DCA advises the partners of professional practices on business development strategies.

Research based drug delivery company
DCA is retained to develop licensing and strategic alliance programmes for the company.

Technology Acquisition
DCA is retained by the heads of new product development in several international companies to identify technology, process and product opportunities.

Venture Capital
DCA advises risk capital and asset managers on managing their technology based investment portfolios and developing suitable exit strategies.

For further information about DCA and our activities please use the menu above. Alternatively, you can always contact us if you have a specific query.

read more


“Consultancy firms don’t carry out assignments. Individuals do”.

Igor S Popovich: “Managing consultants: How to choose and work with” consultants.



What our clients say about us:

Pfizer Inc
“Your assistance has been invaluable.”

Studio Legale Rinaldi e Associati
“After many years of working with David Cooper Associates, I realise that DCA stands for Discernment, Courtesy and Achievement”.

Consortium Capital LLC
“We have worked with DCA since 1994 and in 1996; DCA became our exclusive representative in the UK. Our expectations regarding DCA have been exceeded by Mr. Cooper’s talents and enthusiasm. Mr. Cooper’s creativity and responsiveness to our activities involving complex technology acquisitions and financial transactions ensure a long-term working relationship between our firms.”

Independent Health Source
“We utilized DCA to provide an understanding of medical services in Europe and to negotiate complex transactions for North American clients…DCA’s particular talents lie in its range of contacts, scope of vision and industry overview….they have provided thoughtful and precise oversight on all projects and their impeccable industry knowledge has been integral to our goals”

DynaGen Inc
“As a consultant to our company for ten years, David Cooper has consistently provided the highest calibre of services…from introducing us to UK and international companies to identifying and evaluating various medical technologies and product opportunities and facilitating meetings with potential investors…he has also been invaluable as an intermediary in our dealings with academic consultants and business associates… Mr. Cooper’s efforts on our behalf are characterised by a high degree of professionalism, dependability, and efficiency.”

Pfizer Central Research
“David Cooper Associates were extremely helpful in locating important technologies in Europe, and in support of our pharmaceutical discovery effort, your assistance was an essential ingredient for success.”

Amity Healthcare Capital
“I have worked with David Cooper for many years and on numerous assignments. The projects have ranged from complex cross border M&A and refinancing transactions to commercial and business development arrangements. Professionally I have always gained great satisfaction from working with David and I know this is the case with the other professionals involved. David has a wealth of experience across the globe with a network to match and will always bring an extra value added dimension.”

For further information about DCA and our activities please use the menu above. Alternatively, you can always contact us if you have a specific query.

read more